×

To enhance security, Multi-Factor Authentication (MFA) is mandatory for all HL7 users. More information

 

Specialty Medication Prescribing (PSS in Confluence)

Basics

Specialty Medication Prescribing (PSS in Confluence)

1573
Ballot - STU


FHIR Implementation Guide; FHIR Profile

Create New Standard, Implementation Guide

Details

The goal of this project is to create a co-branded FHIR implementation Guide (Co-branded between HL7 and NCPDP) focused on exchange of data (Demographic, prescription, clinical and financial) for dispensing specialty medications by pharmacies as well as facilitating enrollment of patients in programs offered by third parties such as Hub vendors and Pharmaceutical manufacturers.


By 2020, a projected 9 out of 10 top selling-drugs by revenue will be Specialty. Examples of specialty medication categories include Oncology, Rheumatoid Arthritis, Infusion drugs, etc. The current process for exchanging data, including prescription data regarding specialty medications is complex and manual, taking days to weeks to begin a patient on therapy. There is no industry standard for exchanging clinical data when necessary for dispensing specialty medications by pharmacies as well as facilitating enrollment of patient in programs offered by third parties such as Hub vendors or Pharmaceutical Manufacturers. NCPDP started a task group several years ago focused on the exchange of data needed to help shorten the time to therapy for a patient who has been prescribed a specialty medication and over the past two years have been focused on identifying demographic, clinical and financial information that needs to be exchanged in order to get the patient the therapy they need. This information is outside of the current e-Prescription that is sent to the pharmacy today. After an extensive analysis of the types of additional information that is required along with the prescription it was determined that developing an implementation guide using HL7 FHIR would be the best approach to support the exchange of this information.



UPDATES: TARGET FOR STU2 - JUNE 2022 BALLOT CYCLE PSS Approved - 21 February 2020 NIB - 5 July 2020 Content Complete - 19 July 2020 Submit for Ballot - 9 August 2020


https://confluence.hl7.org/display/PHAR/Specialty+Medication+Prescribing

NCPDP


Standards Development Organizations (SDOs),EHR, PHR; Health Care IT

EHRs, Pharmacies, Intermediaries.


Specialty enrollment, specialty referrals, hub enrollment, manufacturer enrollment, pharmacy


Yes


Yes

2025 May: TSC approved a 2 year extension of Specialty Medication Enrollment FHIR IG STU2 2023 March: TSC approved STU Publication Request for Specialty Medication Enrollment 2021 June: TSC approved STU Publication Request for Specialty Medication Enrollment Sept 2020 Project review: Expect to ballot in January 2021. Milestone date January 2021 WGM January 2021 Project review: Balloting in May 2021. Updated milestone date to May 2021 WGM
Organization & Realm

Realm Specific - Enter "U.S." or name of HL7 Affiliate below

U.S.
People

Melva Peters



Pharmacy Work Group

Orders and Observations Work Group; Patient Care Work Group

Status & Dates

Active

STU - Test Period/Accepting Comments

02/17/2020

01/01/2027

2027 Jan WGM/Ballot

09/01/2026

2026 Sept WGM/Ballot

2022 Sept Ballot Cycle Info: STU Ballot results: Met basic vote requirements. 3 Negatives to reconcile Document Name: HL7/NCPDP FHIR Implementation Guide: Specialty Medication Enrollment, Release 1 - US Realm (See Jira Ballot Dashboard) 2021 Jan Ballot Cycle Info: STU Ballot results: Met basic vote requirements. 5 Negatives to reconcile Document Name: HL7/NCPDP FHIR Implementation Guide: Specialty Medication Enrollment, Release 1 - US Realm
Approvals

12/03/2021


Received


All Received




System Info